Clinical Trial: Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805356) titled 'Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism' on Sept. 01.

Brief Summary: The aim of the study is to evaluate the efficacy, safety, and tolerability of orally administered encaleret tablets in participants with chronic hypoparathyroidism (HP).

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Hypoparathyroidism Chronic Hypoparathyroidism

Intervention: DRUG: Encaleret

Oral tablets

DRUG: Placebo

Oral tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company

Published by HT Digital Content Services with permissi...